4.6 Article

High frequency home-based exercise decreases levels of vascular endothelial growth factor in patients with stable angina pectoris

Journal

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
Volume 22, Issue 5, Pages 575-581

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/2047487314529349

Keywords

Angiogenesis; vascular endothelial growth factor; stromal derived factor-1; exercise; coronary artery disease

Funding

  1. Health and Medical Care Executive Board of the Region Vastra Gotaland
  2. Sahlgrenska University Hospital
  3. Karolinska Hospital
  4. Swedish Heart and Lung Foundation
  5. Swedish Cancer Society
  6. Swedish Research Council
  7. Swedish Pain Foundation (SSF)
  8. Assar Gabrielsson Cancer Research Foundation
  9. LUA/ALF Funding at the Sahlgrenska University Hospital

Ask authors/readers for more resources

Background In coronary artery disease (CAD), circulating angiogenic factors have been seen to increase, possibly as a response to ischaemia. Regular physical activity (PA) is recommended for prevention and treatment of CAD, but more research is needed to optimise PA regimes. We investigated the effect of home-based high frequency exercise (HFE) on angiogenic cytokines and cardiac markers in patients with stable CAD. Design This was a randomised case-control study Methods Sixty-two patients, with stable CAD, were randomised to HFE (n=33), (aerobic exercise 70% of max, 30min, five times/week and resistance exercise three times/week), performed at home, or usual lifestyle (control, n=29). After eight weeks, percutaneous coronary intervention (PCI) was performed in both groups, and the HFE group continued another six months of exercise. Serum vascular endothelial growth factor (VEGF) and stromal derived factor-1 (SDF-1), plasma N-terminal-brain natriuretic peptide (NT-proBNP), high-sensitive troponin T (TnT) and copeptin were analysed. Results Data are presented as median (25(th), 75(th) percentile) of relative changes (%) from baseline. Values of p are given for the difference between the HFE and controls. HFE decreased circulating VEGF levels, before PCI (-5% (-15%, -2%)), while VEGF levels increased in the control group (5% (-3%, 20%) p=0.004). A significant difference in VEGF remained at three months post-PCI (HFE (-1%(-12%, 5%), control (7% (0%, 14%), p=0.04), but not at six months after PCI. SDF-1, NT-proBNP, TnT and copeptin levels did not differ significantly. In addition, VEGF levels were positively correlated to NT pro-BNP. Conclusions Home-based HFE decreased circulating VEGF in patients with stable CAD, suggesting a reduced ischaemic burden. HFE does not increase markers of cardiac dysfunction, suggesting that it is a safe therapeutic intervention in these patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available